| Name | 4,4'-Dimethoxybenzil |
| Synonyms | p-Anisil P-P'-DIMETHOXYBENZIL 4,4'-Dimethoxybenzil p-Anisil, Di-p-anisoyl Di(4-methoxyphenyl) diketone Bis(4-methoxyphenyl)ethanedione bis(4-methoxyphenyl)-ethanedion 1,2-Di(4-methoxyphenyl)ethanedione Bis(4-methoxyphenyl)-1,2-ethanedione 1,2-bis(4-methoxyphenyl)ethane-1,2-dione 1,2-Bis(4-methoxyphenyl)-1,2-ethanedione |
| CAS | 1226-42-2 |
| EINECS | 214-960-5 |
| InChI | InChI=1/C16H14O4/c1-19-13-7-3-11(4-8-13)15(17)16(18)12-5-9-14(20-2)10-6-12/h3-10H,1-2H3 |
| Molecular Formula | C16H14O4 |
| Molar Mass | 270.28 |
| Density | 1.2117 (rough estimate) |
| Melting Point | 132-134°C(lit.) |
| Boling Point | 373.4°C (rough estimate) |
| Flash Point | 197.5°C |
| Water Solubility | Insoluble in water. |
| Vapor Presure | 5.13E-08mmHg at 25°C |
| Appearance | Yellow fine crystalline powder |
| Color | Yellow |
| BRN | 531345 |
| Storage Condition | Sealed in dry,Room Temperature |
| Refractive Index | 1.5447 (estimate) |
| MDL | MFCD00008405 |
| In vitro study | By reducing irinotecaninduced diarrhea, hiCE inhibitors (e.g., 4,4'-Dimethoxybenzil, Compound 8) can improve the anti-cancer efficacy of irinotecan. To find effective hiCE inhibitors, a new virtual screening protocol that combines pharmacophore models derived from the hiCE structure and its ligands has been proposed. |
| Hazard Symbols | Xi - Irritant![]() |
| Risk Codes | 36/37/38 - Irritating to eyes, respiratory system and skin. |
| Safety Description | S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. S36/37 - Wear suitable protective clothing and gloves. S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. |
| WGK Germany | 3 |
| TSCA | Yes |
| HS Code | 29145090 |
| EPA chemical information | Information provided by: ofmpub.epa.gov (external link) |
| biological activity | 4,4 '-Dimethoxybenzil is a human gastrointestinal carboxyl esterase (hCCE) inhibitor with a Ki of 70 nM. |
| target | Ki: 70 nM ( hiCE ) |